Here we share the first of a four-part series of bitesize videos, featuring expert-led discussions on the challenges of global pharmaceutical forecasting.
Gain insight from David James, CEO of J+D Forecasting, and Sanobar Syed, Pharmaceutical Advisor for the top 10 Pharma companies in the world.
*5 minute watch
Part two will focus on solutions for scotch-taped models that are unfit for purpose.
Discover AI’s impact on pharmaceutical forecasting, from early disease detection to personalized treatment strategies in our upcoming webinar.
Announcing the launch of J+D’s expanded services, designed to support the specific forecasting needs of pharmaceutical and biotech clients.
Always innovating to meet client demand, we are pleased to announce an upgrade to the FC365 forecasting platform with our Enhanced Analytics offering.
As the pharmaceutical industry contends with growing financial pressures, we examine its strategic outlook for 2024. How does the sector intend to align with projected commercial objectives while continuing to meet patient needs and what are the implications for forecasting teams?